

24 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251124261066/en/Harmony-Biosciences-Announces-Positive-Results-From-the-Pivotal-Bioequivalence-Study-for-Pitolisant-Gastro-Resistant-Formulation

15 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/viatris-completes-acquisition-of-aculys-pharma-including-exclusive-rights-to-pitolisant-in-japan-and-to-spydia-in-japan-and-certain-other-markets-in-the-asia-pacific-region-302585421.html

05 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250605623408/en/Harmony-Biosciences-Strengthens-Patent-Position-With-Favorable-Settlement-in-ANDA-Litigation

19 Feb 2025
// BUSINESSWIRE

25 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/harmony-biosciences-acknowledges-us-food--drug-administration-fda-action-denying-the-citizen-petition-for-wakix-pitolsiant-302181609.html

24 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/harmony-biosciences-receives-us-food-and-drug-administration-approval-for-wakix-pitolisant-in-pediatric-patients-with-narcolepsy-302179754.html